Edwards Lifesciences Corp (EW)
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE
$92.28
+1.43%
Investingg Score
63.1 / 100
Hold
Business overview
- Gross margin of 78%
- Operating margin of 20.8%
- Free cash flow margin of 22%
These high operating and gross margins demonstrate strong core profitability and efficient cash conversion in its surgical appliance business.
Financial health
- Balance sheet pillar score of 99
- Risk pillar score of 90
- Overall Investingg Score of 63.1 with a Hold verdict
The exceptionally high balance sheet and risk scores indicate a very sturdy financial position with limited downside risk from leverage.
- Gross Margin
- 78.0%
- Operating Margin
- 20.8%
- Current Ratio
- 3.7x
- Debt / Equity
- 0.06
- Free Cash Flow (TTM)
- $1.3B
- Interest Coverage
- 62x
Valuation
- P/E ratio of 42.98
- Forward P/E of 30.71
- Free cash flow yield of 2.5%
A trailing P/E near 43 and a modest free cash flow yield of 2.5% suggest that the stock is priced at a premium relative to its current earnings output.
- P/E (TTM)
- 43.0x
- Forward P/E
- 30.7x
- Price / Sales
- 8.3x
- EV / EBITDA
- 27.5x
- FCF Yield
- 2.5%
Key risks
- Sharp year-over-year decline in earnings per share of -73.7% creates fundamental uncertainty.
- Elevated valuation with a trailing P/E ratio of 42.98 leaves little room for execution errors.
- Relative strength index of 69.12 points to potential short-term overbought conditions.
Market cap $53.6B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze EW with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.